Enavate Sciences’s Zenas BioPharma, Inc. Common Stock ZBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.4M Hold
3,761,359
20.65% 3
2025
Q1
$29.7M Hold
3,761,359
22.39% 2
2024
Q4
$30.8M Buy
+3,761,359
New +$30.8M 22.12% 3